Immune‐mediated disruption of the blood–brain barrier after intracerebral hemorrhage: Insights and potential therapeutic targets
CNS Neuroscience & Therapeutics · 2024-07 · 30 (7)
DOI: 10.1111/cns.14853 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 21.07.2024. Verfasst von Peijun Jia und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pain Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Cerebral Hemorrhage. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Aims
Intracerebral hemorrhage (ICH) is a condition that arises due to the rupture of cerebral blood vessels, leading to the flow of blood into the brain tissue. One of the pathological alterations that occurs during an acute ICH is an impairment of the blood–brain barrier (BBB), which leads to severe perihematomal edema and an immune response.
Discussion
A complex interplay between the cells of the BBB, for example, pericytes, astrocytes, and brain endothelial cells, with resident and infiltrating immune cells, such as microglia, monocytes, neutrophils, T lymphocytes, and others accounts for both damaging and protective mechanisms at the BBB following ICH. However, the precise immunological influence of BBB disruption has yet to be richly ascertained, especially at various stages of ICH.
Conclusion
This review summarizes the changes in different cell types and molecular components of the BBB associated with immune‐inflammatory responses during ICH. Furthermore, it highlights promising immunoregulatory therapies to protect the integrity of the BBB after ICH. By offering a comprehensive understanding of the mechanisms behind BBB damage linked to cellular and molecular immunoinflammatory responses after ICH, this article aimed to accelerate the identification of potential therapeutic targets and expedite further translational research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pain Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Department of Human Anatomy, School of Basic Medical Sciences of Zhengzhou University, Zhengzhou, China.
- School of Life Sciences, Zhengzhou University, Zhengzhou, China.
- David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.
- George Washington School of Medicine and Health Sciences, Washington, DC, USA.
- Department of Neurology, Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, China.
ORCID-Profile: Simon Liu, Marietta Zille, Xuemei Chen, Jian Wang
Förderung
- the National Natural Science Foundation of China
- National Natural Science Foundation of China
Zitieren
APA
Jia, P., Peng, Q., Fan, X., Zhang, Y., Xu, H., Li, J., Sonita, H., Liu, S., Le, A., Hu, Q., Zhao, T., Zhang, S., Wang, J., Zille, M., Jiang, C., Chen, X., & Wang, J. (2024). Immune‐mediated disruption of the blood–brain barrier after intracerebral hemorrhage: Insights and potential therapeutic targets. CNS Neuroscience & Therapeutics, 30(7). https://doi.org/10.1111/cns.14853
Vancouver
Jia P, Peng Q, Fan X, Zhang Y, Xu H, Li J, et al. Immune‐mediated disruption of the blood–brain barrier after intracerebral hemorrhage: Insights and potential therapeutic targets. CNS Neuroscience & Therapeutics. 2024;30(7). doi:10.1111/cns.14853
BibTeX
@article{Jia2024,
author = {Jia, Peijun and Peng, Qinfeng and Fan, Xiaochong and Zhang, Yumeng and Xu, Hanxiao and Li, Jiaxin and Sonita, Houn and Liu, Simon and Le, Anh and Hu, Qiongqiong and Zhao, Ting and Zhang, Shijie and Wang, Junmin and Zille, Marietta and Jiang, Chao and Chen, Xuemei and Wang, Jian},
title = {Immune‐mediated disruption of the blood–brain barrier after intracerebral hemorrhage: Insights and potential therapeutic targets},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
volume = {30},
number = {7},
doi = {10.1111/cns.14853}
}
EUVIMED